Affiliation:
1. Urals Research Center for Radiation Medicine of the Federal Medical Biological Agency, Chelyabinsk, Russia
Abstract
Assessment of individual responses of cells, tissues and the whole body to radiation exposure is an important challenge for radiobiology and radiation safety. The study was aimed to develop the method for estimation of the human hematopietic stem cell (HSC) individual response in the humanized mouse model. The cord blood or peripheral blood HSCs were administered to the NOD SCID immunodeficient mice. The number of maturing HSCs (CD34+ cells) and mature CD45+ leukocytes was assesed after the acute gamma exposure to the doses of 0.5 Gy, 1 Gy, and 1.5 Gy, along with the HSC share among all CD45low/+ cells within three days (period of maximum mortality) and 14 days (period of active restoration) after exposure. The relationship between the indicato values and the exposure dose was calculated by regression analysis. There was exponential relationship between the human HSC survival rate in humanized mice and the dose on day three after exposure (R2 = 0.93; F = 211; p < 0.01), while the relationship between the number of HSCs and the dose on day 14 after exposure was linear (R2 = 0.65; F = 12.9; p = 0.01). The C14/3 coefficient calculated as a ratio of the HSC share among all human CD45low/+ cells on day 14 after exposure to the same parameter on day three after exposure was proposed as an indicator of HSC mortality and HSC number restoration. C14/3 negatively correlated with the exposure dose (R2 = 0.57; F = 13.3; p = 0.004), it was higher in radioresistant mice and the model of cysteamine-induced radioresistance in humanized mice. The model mice humanized using the peripheral blood HSCs can be used to assess individual HSC response to acute external gamma exposure based on C14/3 and the data on the HSC survival and restoration.
Publisher
Federal Medical Biological Agency
Subject
General Chemical Engineering,General Chemistry,Ecology, Evolution, Behavior and Systematics,Organic Chemistry,Biochemistry,Drug Discovery,Bioengineering,Cardiology and Cardiovascular Medicine,Ophthalmology,Political Science and International Relations,Communication,General Chemical Engineering,General Chemistry,Law,Sociology and Political Science,Developmental Biology
Reference25 articles.
1. Xaitov RM, Akleev AV, Kofiadi IA. Individual'naya radiochuvstvitel'nost' i immunitet: nacional'noe rukovodstvo. Chelyabinsk: Kniga, 2018; 216 s. Russian.
2. Applegate KE, Rühm W, Wojcik A, Bourguignon M, Brenner A, Hamasaki K, et al Individual response of humans to ionising radiation: governing factors and importance for radiological protection. Radiat Environ Biophys. 2020; 59 (2): 185–209. DOI: 10.1007/s00411-020-00837-y. PMID: 32146555.
3. Human Radiosensitivity. Report of the independent Advisory Group on Ionising Radiation Documents of the Health Protection Agency. London, 2013; 164 p.
4. Ferlazzo ML, Bourguignon M, Foray N. Functional Assays for Individual Radiosensitivity: A Critical Review. Semin Radiat Oncol. 2017; 27 (4): 310–5. DOI: 10.1016/j.semradonc.2017.04.003. PMID: 28865513.
5. Kogarko IN, Akleev AV, Petushkova VV, Nejfax EA, Kogarko BS, Ktitorova OV, i dr. Adaptivnyj otvet kak kriterij ocenki individual'noj radiochuvstvitel'nosti cheloveka. Radiaciya i risk (Byulleten' NREhR). 2022; 1. Dostupno po ssylke: https://cyberleninka.ru/article/n/adaptivnyy-otvet-kak-kriteriy-otsenki-individualnoy-radiochuvstvitelnosti-cheloveka-obzor (data obrashheniya: 08.11.2022). Russian.